J.T. Lie, MD
This content is PDF only. Please click on the PDF icon to access.
Sakakibara and Konno in 1962 (1) and 1963 (2) first described a safe technique for transvascular, closed chest, right and left ventricular endomyocardial biopsy. Ten years later Caves and associates (3-5) adopted the technique as a useful diagnostic tool for the management of cardiac allograft rejection. In less than a decade, the role of endomyocardial biopsy has been expanded to include the diagnosis of doxorubicin cardiotoxicity, primary and secondary myocardial diseases, and myocarditis (6).
Despite endorsements by some investigators (6-8), the diagnostic yield of endomyocardial biopsy for myocarditis in patients with unexplained heart failure appears to be as predictable as
Lie J. Myocarditis and Endomyocardial Biopsy in Unexplained Heart Failure: A Diagnosis in Search of a Disease. Ann Intern Med. 1988;109:525–528. doi: https://doi.org/10.7326/0003-4819-109-7-525
Download citation file:
Published: Ann Intern Med. 1988;109(7):525-528.
Cardiology, Heart Failure.
Copyright © 2019 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use